AZITHROMYCIN LACTOBIONATE
UNII 4G45QWD7VU

Substance Identification & Data

This profile provides standardized clinical and technical data for Azithromycin Lactobionate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4G45QWD7VU.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 305831-47-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4G45QWD7VU

CAS Registry Number

305831-47-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

AZITHROMYCIN LACTOBIONATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C38H72N2O12.C12H22O12

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

LSWABROAGKFLCB-KJWJCWPASA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C217755

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

49854441

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@]1([C@@H]([C@H](C[C@H](O1)C)N(C)C)O)(O[C@@H]2[C@H]([C@@H]([C@H](C(O[C@@H]([C@](O)(C)[C@@H]([C@H](N(C[C@@H](C[C@]2(O)C)C)C)C)O)CC)=O)C)O[C@]3(C[C@](OC)(C)[C@H]([C@@H](O3)C)O)[H])C)[H].O1[C@@H]([C@@H]([C@@H]([C@H]([C@@H]1O[C@H]([C@@H](CO)O)[C@@H]([C@H](C(O)=O)O)O)O)O)O)CO

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Azithromycin Lactobionate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

AZITHROMYCIN LACTOBIONATE

AZITHROMYCIN LACTOBIONATE [WHO-DD]

Systematic Nomenclature

1-OXA-6-AZACYCLOPENTADECAN-15-ONE, 13-((2,6-DIDEOXY-3-C-METHYL-3-O-METHYL-.ALPHA.-L-RIBO-HEXOPYRANOSYL)OXY)-2-ETHYL-3,4,10-TRIHYDROXY-3,5,6,8,10,12,14-HEPTAMETHYL-11-((3,4,6-TRIDEOXY-3-(DIMETHYLAMINO)-.BETA.-D-XYLO-HEXOPYRANOSYL)OXY)-, (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-, MONO(4-O-.BETA.-D-GALACTOPYRANOSYL-D-GLUCONATE) (SALT)

SYS

D-GLUCONIC ACID, 4-O-.BETA.-D-GALACTOPYRANOSYL-, COMPD. WITH (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-((2,6-DIDEOXY-3-C-METHYL-3-O-METHYL-.ALPHA.-L-RIBO-HEXOPYRANOSYL)OXY)-2-ETHYL-3,4,10-TRIHYDROXY-3,5,6,8,10,12,14-HEPTAMETHYL-11-((3,4,6-TRIDEOXY-3-(DIMETHYLAMINO)-.BETA.-D-XYLO-HEXOPYRANOSYL)OXY)-1-OXA-6-AZACYCLOPENTADECAN-15-ONE (1:1)

SYS

External Clinical & Regulatory Resources

Previous UNII4G44846RZ0

Next UNII4G4CX2K6XM